These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 33719816)

  • 1. Individual, social and structural factors influencing PrEP uptake among cisgender women: a theory-informed elicitation study.
    Teitelman AM; Tieu HV; Flores D; Bannon J; Brawner BM; Davis A; Gugerty P; Koblin B
    AIDS Care; 2022 Mar; 34(3):273-283. PubMed ID: 33719816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Just4Us: Development of a Counselor-Navigator and Text Message Intervention to Promote PrEP Uptake Among Cisgender Women at Elevated Risk for HIV.
    Teitelman AM; Koblin BA; Brawner BM; Davis A; Darlington C; Lipsky RK; Iwu E; Bond KT; Westover J; Fiore D; Tieu HV
    J Assoc Nurses AIDS Care; 2021 Mar-Apr 01; 32(2):188-204. PubMed ID: 33427767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beliefs Associated with Intention to Use PrEP Among Cisgender U.S. Women at Elevated HIV Risk.
    Teitelman AM; Chittamuru D; Koblin BA; Davis A; Brawner BM; Fiore D; Broomes T; Ortiz G; Lucy D; Tieu HV
    Arch Sex Behav; 2020 Aug; 49(6):2213-2221. PubMed ID: 32270399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Women's views on communication with health care providers about pre-exposure prophylaxis (PrEP) for HIV prevention.
    Jackson GY; Darlington CK; Van Tieu H; Brawner BM; Flores DD; Bannon JA; Davis A; Frye V; Chittamuru D; Gugerty P; Koblin BA; Teitelman AM
    Cult Health Sex; 2022 May; 24(5):642-656. PubMed ID: 33535887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "PrEP"ing for a PrEP demonstration project: understanding PrEP knowledge and attitudes among cisgender women.
    Pasipanodya EC; Stockman J; Phuntsog T; Morris S; Psaros C; Landovitz R; Amico KR; Moore DJ; Blumenthal J
    BMC Womens Health; 2021 May; 21(1):220. PubMed ID: 34034719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Moderating Effects of HIV Relevant Factors on the Relationship Between Intimate Partner Violence and Intention to Start HIV Pre-exposure Prophylaxis (PrEP) Among Cisgender Women.
    Keddem S; Frye V; Davis A; Koblin BA; Tieu HV; Lipsky RK; Nandi V; Teitelman AM
    Arch Sex Behav; 2024 Apr; 53(4):1531-1539. PubMed ID: 38366311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intention to Initiate HIV Pre-exposure Prophylaxis Among Cisgender Women in a High HIV Prevalence U.S. City.
    Scott RK; Hull SJ; Huang JC; Ye PP; Lotke P; Beverley J; Moriarty P; Balaji D; Ward A; Holiday J; Brant AR; Elion R; Visconti AJ; Coleman M
    Womens Health Issues; 2023; 33(5):541-550. PubMed ID: 37479630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A survey with interventional components delivered on tablet devices versus usual care to increase pre-exposure prophylaxis uptake among cisgender Black women: a pilot randomized controlled trial.
    Hill MJ; Heads AM; Suchting R; Stotts AL
    BMC Infect Dis; 2023 Jan; 23(1):57. PubMed ID: 36707778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors Associated with Intention to Initiate Pre-exposure Prophylaxis in Cisgender Women at High Behavioral Risk for HIV in Washington, D.C.
    Scott RK; Hull SJ; Huang JC; Coleman M; Ye P; Lotke P; Beverley J; Moriarty P; Balaji D; Ward A; Holiday J; Brant AR; Cameron M; Elion R; Visconti A
    Arch Sex Behav; 2022 Jul; 51(5):2613-2624. PubMed ID: 35622077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. "PrEP's just to secure you like insurance": a qualitative study on HIV pre-exposure prophylaxis (PrEP) adherence and retention among black cisgender women in Mississippi.
    Willie TC; Monger M; Nunn A; Kershaw T; Stockman JK; Mayer KH; Chan PA; Adimora AA; Mena LA; Knight D; Philllips KA; Baral SD
    BMC Infect Dis; 2021 Oct; 21(1):1102. PubMed ID: 34702165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Where's the "Everyday Black Woman"? An intersectional qualitative analysis of Black Women's decision-making regarding HIV pre-exposure prophylaxis (PrEP) in Mississippi.
    Willie TC; Knight D; Baral SD; Chan PA; Kershaw T; Mayer KH; Stockman JK; Adimora AA; Monger M; Mena LA; Philllips KA; Nunn A
    BMC Public Health; 2022 Aug; 22(1):1604. PubMed ID: 35999528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Let Me Prep You to PREP Me: Amplifying the Voices of Black Women and Their Providers to Consider PrEP as an HIV Prevention Option.
    Chandler R; Guillaume D; Wells J; Hernandez N
    Int J Environ Res Public Health; 2022 Jan; 19(3):. PubMed ID: 35162438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identifying Implementation Strategies to Enhance HIV Pre-Exposure Prophylaxis Uptake Among Black Cisgender Women in New Orleans, Louisiana.
    Clement ME; Perry B; McKenna K; Beckford J; Davenport T; Murray E; Magee V; Bickham JN; Siren J; Smith A; Lillis R; Corneli A
    AIDS Patient Care STDS; 2024 Mar; 38(3):144-150. PubMed ID: 38471093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A secondary gendered analysis of interviews with Latina cisgender women indicated for HIV pre-exposure prophylaxis.
    Lim S; Mantsios A; Braithwaite RS; Pitts R
    AIDS Care; 2024 May; 36(5):692-702. PubMed ID: 38466205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pre-exposure Prophylaxis (PrEP) Initiation Among Black and Latina Cisgender Women Receiving HIV Prevention Care Coordination Services in New York City.
    Cheek JB; Feldman MB; Montero N; Gambone GF; Hoffman S; Blackstock OJ
    AIDS Behav; 2022 Oct; 26(10):3174-3184. PubMed ID: 35362904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Barriers and facilitators to HIV pre-exposure prophylaxis for cisgender and transgender women in the UK.
    Whelan I; Strachan S; Apea V; Orkin C; Paparini S
    Lancet HIV; 2023 Jul; 10(7):e472-e481. PubMed ID: 37271160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Barriers and facilitators to pre-exposure prophylaxis uptake among male sex workers in Mexico: an application of the RE-AIM framework.
    Kadiamada-Ibarra H; Hawley NL; Sosa-Rubí SG; Wilson-Barthes M; Franco RR; Galárraga O
    BMC Public Health; 2021 Nov; 21(1):2174. PubMed ID: 34837988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Provider Perspectives on Factors Affecting the PrEP Care Continuum Among Black Cisgender Women in the Midwest United States: Applying the Consolidated Framework for Implementation Research.
    Johnson AK; Pyra M; Devlin S; Uvin AZ; Irby S; Blum C; Stewart E; Masinter L; Haider S; Hirschhorn LR; Ridgway JP
    J Acquir Immune Defic Syndr; 2022 Jul; 90(S1):S141-S148. PubMed ID: 35703766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uptake of and adherence to oral pre-exposure prophylaxis among adolescent girls and young women at high risk of HIV-infection in Kampala, Uganda: A qualitative study of experiences, facilitators and barriers.
    Kayesu I; Mayanja Y; Nakirijja C; Machira YW; Price M; Seeley J; Siu G
    BMC Womens Health; 2022 Nov; 22(1):440. PubMed ID: 36357920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing Provider-, Clinic-, and Structural-Level Barriers and Recommendations to Pre-Exposure Prophylaxis (PrEP) Uptake: A Qualitative Investigation Among Women Experiencing Intimate Partner Violence, Intimate Partner Violence Service Providers, and Healthcare Providers.
    Caplon A; Alexander KA; Kershaw T; Willie TC
    AIDS Behav; 2021 Oct; 25(10):3425-3436. PubMed ID: 33974167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.